Korean J Dermatol.
2006 Jan;44(1):113-116.
A Case of Cutaneous Leishmaniasis Treated with Intralesional Injection of Meglumine Antimoniate
- Affiliations
-
- 1Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea. kychung@yumc.yonsei.ac.kr
Abstract
- Cutaneous leishmaniasis is a self-limited infection of skin caused by the genus Leishmania, a protozoan parasite transmitted by sandflies. Although various therapeutic regimens have been tried, no ideal therapy for cutaneous leishmaniasis has yet been identified. We report a case of cutaneous leishmaniasis that was successfully treated with intralesional injection of meglumine antimoniate combined with oral metronidazole.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- New World Cutaneous Leishmaniasis Treated with Intralesional Injection of Pentavalent Antimony
- Cutaneous Leishmaniasis of the Lid: A Report of Nine Cases
- Childhood cutaneous leishmaniasis: report of 117 cases from Iran
- Cutaneous Leishmaniasis of the Eyelids: A Case Series with Molecular Identification and Literature Review
- Cutaneous Leishmaniasis Treated with Metronidazole and Cryotherapy
